Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
There is a substantial heterogeneity in adoption of multi-gene assays in Europe.
In a survey among physicians with at least 5 years of experience in treatment of breast cancer, a majority of respondents indicated they would use multi-gene assays in clinical practice, but the main perceived barriers for usage are reimbursement, price and lack of availability, according to the survey results presented by Dr Matti Aapro of the Multidisciplinary Oncology Institute, Geneva, Switzerland.
Read the article in full here.
Source: ESMO
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.